Tecartus cells dispersion for infusion

Company:
Gilead Sciences Ltd
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Brexucabtagene Autoleucel
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/20/1492/001

0.4 – 2 × 10^8 cells

Dispersion for infusion